SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Mauricette Michallet, Karine Goldet, Mohamad Sobh, Stéphane Morisset, Youcef Chelghoum, Xavier Thomas, Fiorenza Barraco, Sophie Ducastelle, Hélène Labussière, Catherine Renzullo, Carole Paillet, Christine Pivot, Perrine Badol-Van Straaten, Angelique Denis, Anne Termoz, Marie Detrait, Franck-Emmanuel Nicolini, Isabelle Jaisson-Hot, Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients, Cancer, 2013, 119, 1
  2. 2
    Jean-Luc Canon, Johan Vansteenkiste, Michael Hedenus, Pere Gascon, Carsten Bokemeyer, Heinz Ludwig, Jan Vermorken, Jason Legg, Beatriz Pujol, Ken Bridges, Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial, Medical Oncology, 2012, 29, 3, 2291

    CrossRef

  3. 3
    Aknar Calabrich, Artur Katz, Management of anemia in cancer patients, Future Oncology, 2011, 7, 4, 507

    CrossRef

  4. 4
    D. H. Henry, Parenteral Iron Therapy in Cancer-Associated Anemia, Hematology, 2010, 2010, 1, 351

    CrossRef

  5. 5
    John A. Glaspy, Erythropoietin in Cancer Patients, Annual Review of Medicine, 2009, 60, 1, 181

    CrossRef

  6. 6
    Stacy S. Shord, Michael Auerbach, Treating chemotherapy-induced anemia following the revised labeling for ESAs, Community Oncology, 2009, 6, 6, 279

    CrossRef

  7. 7
    John Glaspy, Erythropoiesis-Stimulating Agents and the Practice of Gynecologic Oncology, Clinical Ovarian Cancer, 2008, 1, 1, 44

    CrossRef

  8. 8
    J.H. Schouwink, H. Codrington, H.P. Sleeboom, L.G.M. Kerkhofs, L.W. Wormhoudt, Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy, European Journal of Cancer, 2008, 44, 6, 819

    CrossRef

  9. 9
    I. Ray-Coquard, D. Kassab-Chahmi, N. Casadevall, P. Chastagner, C. Marchal, P. Marec-Bérard, J. -L. Misset, Standards, Options: Recommandations pour I’indication des agents stimulant l’érythropoïèse (ASE: époétine alpha, époétine bêta et darbépoétine) dans la prise en charge de l’anémie en cancérologie (mise à jour 2007), rapport abrégé, Oncologie, 2008, 10, 2, 160

    CrossRef

  10. 10
    J. D. Rizzo, M. R. Somerfield, K. L. Hagerty, J. Seidenfeld, J. Bohlius, C. L. Bennett, D. F. Cella, B. Djulbegovic, M. J. Goode, A. A. Jakubowski, M. U. Rarick, D. H. Regan, A. E. Lichtin, Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update, Blood, 2008, 111, 1, 25

    CrossRef

  11. 11
    John Glaspy, Cancer Supportive Care: Advances in Therapeutic Strategies, 2008,

    CrossRef

  12. 12
    Bonne Biesma, Paul R. van de Werf, Christian F. Melissant, Ronald G.P.M. Brok, Anaemia management with epoetin alfa in lung cancer patients in The Netherlands, Lung Cancer, 2007, 58, 1, 104

    CrossRef

  13. 13
    Janice L. Gabrilove, Edith A. Perez, Dianne K. Tomita, Greg Rossi, Charles S. Cleeland, Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia, Cancer, 2007, 110, 7
  14. 14
    James G. Stevenson, James J. Natale, Darbepoetin alfa: An Effective Treatment with Flexible and Simplified Dosing for Anemia in Patients with Cancer, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007, 27, 3
  15. 15
    Gunnar Birgegård, Epoetin treatment in haematologic malignancy: How to improve response?, European Journal of Cancer Supplements, 2007, 5, 5, 436

    CrossRef

  16. 16
    J.-M. Bréchot, CBNPC et soins complémentaires Quels traitements de support en cancérologie thoracique ?, Revue des Maladies Respiratoires, 2006, 23, 5, 100

    CrossRef

  17. 17
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2006, 15, 7
  18. 18
    Pierre Soubeyran, Javier de Castro, Optimising the response to epoetin beta for the treatment of cancer-related anaemia, Current Medical Research and Opinion, 2006, 22, s4, S35

    CrossRef